IL154769D0 - Cardiac arrhythmia treatment methods - Google Patents

Cardiac arrhythmia treatment methods

Info

Publication number
IL154769D0
IL154769D0 IL15476901A IL15476901A IL154769D0 IL 154769 D0 IL154769 D0 IL 154769D0 IL 15476901 A IL15476901 A IL 15476901A IL 15476901 A IL15476901 A IL 15476901A IL 154769 D0 IL154769 D0 IL 154769D0
Authority
IL
Israel
Prior art keywords
treatment methods
cardiac arrhythmia
arrhythmia treatment
cardiac
methods
Prior art date
Application number
IL15476901A
Original Assignee
Univ Johns Hopkins
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US23031100P priority Critical
Priority to US29588901P priority
Application filed by Univ Johns Hopkins filed Critical Univ Johns Hopkins
Priority to PCT/US2001/027623 priority patent/WO2002019966A2/en
Publication of IL154769D0 publication Critical patent/IL154769D0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088Compounds having three or more nucleosides or nucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • A61K38/1858Platelet-derived growth factor [PDGF]
    • A61K38/1866Vascular endothelial growth factor [VEGF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0067Catheters; Hollow probes characterised by the distal end, e.g. tips
    • A61M25/0082Catheter tip comprising a tool
    • A61M25/0084Catheter tip comprising a tool being one or more injection needles
    • A61M2025/0089Single injection needle protruding axially, i.e. along the longitudinal axis of the catheter, from the distal tip
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00Anatomical parts of the body
    • A61M2210/12Blood circulatory system
    • A61M2210/125Heart
IL15476901A 2000-09-06 2001-09-06 Cardiac arrhythmia treatment methods IL154769D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US23031100P true 2000-09-06 2000-09-06
US29588901P true 2001-06-05 2001-06-05
PCT/US2001/027623 WO2002019966A2 (en) 2000-09-06 2001-09-06 Cardiac arrhythmia treatment methods

Publications (1)

Publication Number Publication Date
IL154769D0 true IL154769D0 (en) 2003-10-31

Family

ID=26924110

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15476901A IL154769D0 (en) 2000-09-06 2001-09-06 Cardiac arrhythmia treatment methods

Country Status (7)

Country Link
US (6) US7034008B2 (en)
EP (2) EP2363152A1 (en)
JP (1) JP5106738B2 (en)
AU (2) AU2001288807B2 (en)
CA (1) CA2421584C (en)
IL (1) IL154769D0 (en)
WO (1) WO2002019966A2 (en)

Families Citing this family (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0928135B1 (en) * 1996-07-17 2006-06-14 Medtronic, Inc. System for enhancing cardiac signal sensing by cardiac pacemakers through genetic treatment
US20090175790A1 (en) * 2000-09-06 2009-07-09 The Johns Hopkins University Cardiac arrhythmia treatment methods and biological pacemaker
IL154769D0 (en) * 2000-09-06 2003-10-31 Univ Johns Hopkins Cardiac arrhythmia treatment methods
US7294333B1 (en) * 2000-10-20 2007-11-13 Genegrafts Ltd. Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues
US7699790B2 (en) 2000-12-20 2010-04-20 Ev3, Inc. Debulking catheters and methods
US7927784B2 (en) 2000-12-20 2011-04-19 Ev3 Vascular lumen debulking catheters and methods
EP1409510A4 (en) * 2001-04-27 2004-09-08 Univ Johns Hopkins Biological pacemaker
US6849611B2 (en) * 2001-06-06 2005-02-01 The Trustees Of Columbia University In The City Of New York Implantation of biological pacemaker that is molecularly determined
US6783979B2 (en) * 2001-06-06 2004-08-31 The Trustees Of Columbia University In The City Of New York Research Foundation Of State University Of New York Vectors encoding HCN channels and MiRP1
WO2002098287A2 (en) * 2001-06-06 2002-12-12 The Trustees Of Columbia University In The City Of New York A high throughput biological heart rate monitor that is molecularly determined
US7252819B2 (en) 2001-11-08 2007-08-07 The Regents Of The University Of California Methods and compositions for correction of cardiac conduction disturbances
US6743797B2 (en) * 2002-02-22 2004-06-01 Chantest, Inc. Methods for treating cardiac arrhythmia
US6811777B2 (en) 2002-04-13 2004-11-02 Allan Mishra Compositions and minimally invasive methods for treating incomplete connective tissue repair
CA2487280A1 (en) * 2002-05-08 2003-11-20 The Regents Of The University Of California System and method for forming a substantially non-ablative cardiac conduction block
WO2004030630A2 (en) * 2002-10-02 2004-04-15 The Johns Hopkins University Focal calcium channel modulation
US9398967B2 (en) 2004-03-02 2016-07-26 Syntach Ag Electrical conduction block implant device
EP1605866B1 (en) 2003-03-03 2016-07-06 Syntach AG Electrical conduction block implant device
US20070021375A1 (en) * 2003-04-25 2007-01-25 Vinod Sharma Genetic modification of targeted regions of the cardiac conduction system
US8013133B2 (en) * 2003-04-25 2011-09-06 Medtronic, Inc. Genetic modification of targeted regions of the cardiac conduction system
US20050021089A1 (en) * 2003-07-24 2005-01-27 Medtronic, Inc. Compositions and methods for treating cardiac dysfunction
ITRM20030376A1 (en) 2003-07-31 2005-02-01 Univ Roma Method for the isolation and expansion of cardiac stem cells from biopsy.
JP2007520259A (en) * 2003-11-10 2007-07-26 シンフォニー メディカル, インコーポレイテッド Method for controlling ventricular rate in atrial fibrillation patients
SE526861C2 (en) 2003-11-17 2005-11-15 Syntach Ag The tissue lesion creating device and a set of devices for treatment of disorders in the heart rhythm regulation system
EP1690933B1 (en) 2003-11-17 2013-04-24 Eisai R&D Management Co., Ltd. hERG CHANNEL-EXPRESSING CELL
US20060128647A1 (en) * 2003-12-24 2006-06-15 Daniel Sigg Novel oligonucleotides and treating cardiac disorders by using the same
US8859273B2 (en) * 2003-12-24 2014-10-14 Medtronic, Inc. Methods of using HCN genes to treat cardiac arrhythmias
WO2005062857A2 (en) * 2003-12-24 2005-07-14 The Trustees Of Columbia University In The City Of New York Creation of a biological atrioventricular bypass to compensate for atrioventricular block
US20070134157A1 (en) * 2004-02-26 2007-06-14 Regan Christopher P Biological assay
US7840263B2 (en) * 2004-02-27 2010-11-23 Cardiac Pacemakers, Inc. Method and apparatus for device controlled gene expression
US7764995B2 (en) 2004-06-07 2010-07-27 Cardiac Pacemakers, Inc. Method and apparatus to modulate cellular regeneration post myocardial infarct
US7729761B2 (en) 2004-07-14 2010-06-01 Cardiac Pacemakers, Inc. Method and apparatus for controlled gene or protein delivery
EP1781371A4 (en) * 2004-07-19 2007-12-19 Univ Columbia Assay system for monitoring the effects of genetically engineered cells to alter function of a syncytium
EP1829526B1 (en) * 2004-11-02 2016-01-20 National University Corporation Tokyo Medical and Dental University Liposome and method of injecting substance into cell by using the same
US8060219B2 (en) 2004-12-20 2011-11-15 Cardiac Pacemakers, Inc. Epicardial patch including isolated extracellular matrix with pacing electrodes
US7981065B2 (en) 2004-12-20 2011-07-19 Cardiac Pacemakers, Inc. Lead electrode incorporating extracellular matrix
WO2006084322A1 (en) * 2005-02-09 2006-08-17 Craig Steven Mclachlan Treatment method for modifying tissue passive electrical conductance
US8565898B2 (en) * 2005-04-28 2013-10-22 Medtronic, Inc. Rate control during AF using cellular intervention to modulate AV node
JP2009508538A (en) * 2005-07-29 2009-03-05 ザ・トラスティーズ・オブ・コロンビア・ユニバーシティ・イン・ザ・シティ・オブ・ニューヨーク Compensating conduction block cardiac sodium channel biological bypass bridge with calcium channels and / or potassium channel
US7774057B2 (en) * 2005-09-06 2010-08-10 Cardiac Pacemakers, Inc. Method and apparatus for device controlled gene expression for cardiac protection
JP2009511064A (en) * 2005-10-14 2009-03-19 ザ ジョンズ ホプキンス ユニバーシティー Biological excitable cells
US20070190028A1 (en) * 2006-02-13 2007-08-16 Jihong Qu Method and apparatus for heat or electromagnetic control of gene expression
US7989207B2 (en) 2006-02-17 2011-08-02 Tyco Healthcare Group Lp Testing lumenectomy samples for markers of non-vascular diseases
JP5623740B2 (en) * 2006-07-25 2014-11-12 セラドン・コーポレーション Long antegrade epicardial coronary infusion of gene therapy for adeno-associated virus vectors
US8825677B2 (en) 2006-09-20 2014-09-02 Ebay Inc. Listing generation utilizing catalog information
US20080082415A1 (en) * 2006-09-20 2008-04-03 Vishwanath Shastry Listing generation and advertising management utilizing catalog information
US20100189701A1 (en) * 2006-12-22 2010-07-29 Ira S Cohen Methods and compositions to treat arrhythmias
US20100150887A1 (en) * 2007-01-25 2010-06-17 Duff Henry J Tissue Progenitor Cells That Overexpress ERG
US20090047703A1 (en) * 2007-08-17 2009-02-19 University Of Maryland, Baltimore ERG-1 Peptides and Polynucleotides and Their Use in the Treatment and Diagnosis of Disease
US20090054828A1 (en) * 2007-08-22 2009-02-26 Cardiac Pacemakers, Inc. Systems for transient conduction control
US8311620B2 (en) * 2007-08-22 2012-11-13 Cardiac Pacemakers, Inc. Methods and apparatus to treat and prevent atrial tachyarrhythmias
WO2009036220A2 (en) 2007-09-12 2009-03-19 The Regents Of The University Of California Compositions and methods for improving the functional efficacy of stem cell-derived cardiomyocytes
US20090233990A1 (en) * 2007-11-01 2009-09-17 Hee Cheol Cho Generation of biological pacemaker activity
EP2244740A1 (en) 2008-02-19 2010-11-03 Celladon Corporation Compositions for enhanced uptake of viral vectors in the myocardium
US20110256112A2 (en) * 2008-03-07 2011-10-20 The Trustees Of Columbia University In The City Of New York Compensating for Atrioventricular Block Using a Nucleic Acid Encoding a Sodium Channel or Gap Junction Protein
WO2009120082A2 (en) * 2008-03-27 2009-10-01 Academisch Medisch Centrum Bij De Universiteit Van Amsterdam Means and methods for influencing electrical activity of cells
WO2010042658A1 (en) * 2008-10-07 2010-04-15 Bioparadox, Llc Use of platelet rich plasma composition in the treatment of cardiac conduction abnormalities
WO2011056685A1 (en) * 2009-10-27 2011-05-12 Cedars-Sinai Medical Center External magnetic force for targeted cell delivery with enhanced cell retention
US9393198B2 (en) * 2010-03-22 2016-07-19 Signpath Pharma Inc. Intravenous curcumin and derivatives for treatment of neurodegenerative and stress disorders
US9845457B2 (en) 2010-04-30 2017-12-19 Cedars-Sinai Medical Center Maintenance of genomic stability in cultured stem cells
US9249392B2 (en) 2010-04-30 2016-02-02 Cedars-Sinai Medical Center Methods and compositions for maintaining genomic stability in cultured stem cells
US9271950B2 (en) 2010-10-29 2016-03-01 Infirst Healthcare Limited Compositions for treating chronic inflammation and inflammatory diseases
US20190083624A9 (en) * 2010-10-29 2019-03-21 Infirst Healthcare Limited Solid Solution Compositions and Use in Severe Pain
US9744132B2 (en) 2010-10-29 2017-08-29 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US9308213B2 (en) 2010-10-29 2016-04-12 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US8895537B2 (en) 2010-10-29 2014-11-25 Infirst Healthcare Ltd. Compositions and methods for treating cardiovascular diseases
US8639323B2 (en) 2010-11-01 2014-01-28 Medtronic, Inc. System and apparatus to monitor biopacemaker maturation
WO2012068385A2 (en) 2010-11-18 2012-05-24 Medtronic, Inc. Implantable medical device with swappable headers
US9592398B2 (en) 2011-05-12 2017-03-14 Medtronic, Inc. Leadless implantable medical device with osmotic pump
EP3326616A1 (en) 2011-06-03 2018-05-30 Signpath Pharma Inc. Liposomal mitigation of drug-induced long qt syndrome and potassium delayed-rectifier current
US10117881B2 (en) 2011-06-03 2018-11-06 Signpath Pharma, Inc. Protective effect of DMPC, DMPG, DMPC/DMPG, LYSOPG and LYSOPC against drugs that cause channelopathies
WO2012167212A2 (en) 2011-06-03 2012-12-06 Signpath Pharma Inc. Liposomal mitigation of drug-induced long qt syndrome and potassium delayed-rectifier current
US10238602B2 (en) 2011-06-03 2019-03-26 Signpath Pharma, Inc. Protective effect of DMPC, DMPG, DMPC/DMPG, LysoPG and LysoPC against drugs that cause channelopathies
US9681836B2 (en) 2012-04-23 2017-06-20 Cyberonics, Inc. Methods, systems and apparatuses for detecting seizure and non-seizure states
WO2013184527A1 (en) 2012-06-05 2013-12-12 Capricor, Inc. Optimized methods for generation of cardiac stem cells from cardiac tissue and their use in cardiac therapy
CA2881394A1 (en) 2012-08-13 2014-02-20 Cedars-Sinai Medical Center Exosomes and micro-ribonucleic acids for tissue regeneration
DE112013004278T5 (en) 2012-08-31 2015-05-21 Signpath Pharma Inc. He curcumin, a liposomal PLGA nanocurcumin extended or delayed release to minimize QT prolongation for cancer therapy
GB201309882D0 (en) * 2013-06-03 2013-07-17 Isis Innovation Prevention and treatment of atrial fibrillation
US20140356893A1 (en) 2013-06-04 2014-12-04 Allan Mishra Compositions and methods for using platelet-rich plasma for drug discovery, cell nuclear reprogramming, proliferation or differentiation
US10087436B2 (en) 2014-02-06 2018-10-02 The Regents Of The University Of California Electrophysiologically mature cardiomyocytes and methods for making same
CA2950758A1 (en) 2014-06-03 2015-12-10 Signpath Pharma, Inc. Protective effect of dmpc, dmpg, dmpc/dmpg, egpg, lysopg and lysopc against drugs that cause channelopathies
EP3206702A1 (en) * 2014-10-16 2017-08-23 Academisch Medisch Centrum Nk3 agonist for use in the treatment of a patient suffering from atrial arrhythmia or fibrillation

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5401629A (en) 1990-08-07 1995-03-28 The Salk Institute Biotechnology/Industrial Associates, Inc. Assay methods and compositions useful for measuring the transduction of an intracellular signal
US5163950A (en) * 1990-08-24 1992-11-17 Medical Engineering Corporation Balloon catheter and endoscope kit
JPH10501681A (en) 1994-02-22 1998-02-17 ダナ−ファーバー キャンサー インスティチュート Nucleic acid delivery system as well as synthetic and using the same
US5662585A (en) * 1994-05-05 1997-09-02 Imagyn Medical, Inc. Endoscope with protruding member and method of utilizing the same
US5836905A (en) * 1994-06-20 1998-11-17 Lemelson; Jerome H. Apparatus and methods for gene therapy
US5824550A (en) * 1994-10-28 1998-10-20 Barnes-Jewish Hopital Voltage-gated calcium channel and antisense oligonucleotides thereto
CA2214646A1 (en) 1995-03-09 1996-09-19 University Of Utah Research Foundation Long qt genes and method for diagnosing or preventing the occurrence of long qt syndrome
US6605274B1 (en) * 1995-04-11 2003-08-12 The Regents Of The University Of California Method for in vivo regulation of cardiac muscle contractility
AT427993T (en) * 1995-12-22 2009-04-15 Univ Utah Res Found A GENE OF ßLANGEN QT SYNDROMSß (LONG QT SYNDROME), WHICH KVLQT1 CODES AND ITS INTERACTION WITH MINK
US5944710A (en) 1996-06-24 1999-08-31 Genetronics, Inc. Electroporation-mediated intravascular delivery
CA2262753A1 (en) * 1996-08-02 1998-02-12 Elan Pharmaceuticals, Inc. Voltage-gated calcium channel antagonist and methods
US20020009772A1 (en) * 1997-02-28 2002-01-24 Terry P. Snutch Novel human calcium channels and related probes, cell lines and mehtods
US6086582A (en) 1997-03-13 2000-07-11 Altman; Peter A. Cardiac drug delivery system
US6123699A (en) * 1997-09-05 2000-09-26 Cordis Webster, Inc. Omni-directional steerable catheter
WO1999023880A1 (en) 1997-11-07 1999-05-20 Johns Hopkins University Somatic transfer of modified genes to predict drug effects
US6703485B2 (en) * 1997-12-23 2004-03-09 The Trustees Of Columbia University In The City Of New York Brain and heart cyclic nucleotide gated ion channel compounds and uses thereof
US5965396A (en) * 1998-01-13 1999-10-12 Zeneca Limited Human lymph node derived GTPase
US6776987B1 (en) * 1998-01-13 2004-08-17 Massachusetts Institute Of Technology Enhancement of cardiac chronotropy
US6207422B1 (en) * 1998-04-17 2001-03-27 The Metrohealth System Protein that enhances expression of potassium channels on cell surfaces and nucleic acids that encode the same
US6183444B1 (en) * 1998-05-16 2001-02-06 Microheart, Inc. Drug delivery module
US6623474B1 (en) * 1998-06-04 2003-09-23 Biosense Webster, Inc. Injection catheter with needle stop
US6365337B1 (en) * 1998-07-27 2002-04-02 University Of Iowa Research Foundation Genes encoding neuronal voltage-gated calcium channel gamma subunits
AU6501499A (en) * 1998-09-29 2000-04-17 Johns Hopkins University, The Inducible genetic suppression of cellular excitability
CA2356551A1 (en) * 1998-12-28 2000-07-06 Arch Development Corporation Efficient and stable in vivo gene transfer to cardiomyocytes using recombinant adeno-associated virus vectors
WO2000041731A1 (en) * 1999-01-19 2000-07-20 The Children's Hospital Of Philadelphia Reverse gene therapy
IL154769D0 (en) * 2000-09-06 2003-10-31 Univ Johns Hopkins Cardiac arrhythmia treatment methods
AU1459602A (en) * 2000-10-13 2002-04-22 Univ Johns Hopkins Methods and compositions for nucleic acid delivery
US7294333B1 (en) * 2000-10-20 2007-11-13 Genegrafts Ltd. Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues
EP1409510A4 (en) * 2001-04-27 2004-09-08 Univ Johns Hopkins Biological pacemaker
WO2002098287A2 (en) * 2001-06-06 2002-12-12 The Trustees Of Columbia University In The City Of New York A high throughput biological heart rate monitor that is molecularly determined
US6783979B2 (en) * 2001-06-06 2004-08-31 The Trustees Of Columbia University In The City Of New York Research Foundation Of State University Of New York Vectors encoding HCN channels and MiRP1
WO2004030630A2 (en) * 2002-10-02 2004-04-15 The Johns Hopkins University Focal calcium channel modulation
TW200510527A (en) * 2003-05-28 2005-03-16 Synta Pharmaceuticals Corp Novel calcium channels and uses thereof
CA2575947A1 (en) * 2004-08-02 2006-02-16 The Johns Hopkins University Modulation of bio-electrical rhythms via a novel engineering approach
US9116846B2 (en) 2013-06-10 2015-08-25 Veeam Software Ag Virtual machine backup from storage snapshot

Also Published As

Publication number Publication date
WO2002019966A2 (en) 2002-03-14
EP2363152A1 (en) 2011-09-07
US20050107323A1 (en) 2005-05-19
EP1324780A4 (en) 2005-06-22
EP1324780A2 (en) 2003-07-09
AU2001288807B2 (en) 2007-07-19
CA2421584A1 (en) 2002-03-14
JP5106738B2 (en) 2012-12-26
US20020155101A1 (en) 2002-10-24
US20150183842A1 (en) 2015-07-02
AU8880701A (en) 2002-03-22
CA2421584C (en) 2013-12-31
US20070048284A1 (en) 2007-03-01
JP2004533405A (en) 2004-11-04
US20040266717A1 (en) 2004-12-30
US7034008B2 (en) 2006-04-25
WO2002019966A3 (en) 2002-08-15
US20040266716A1 (en) 2004-12-30

Similar Documents

Publication Publication Date Title
EG22308A (en) Tobacco treatment
TWI292715B (en) Methods for treating skin pigmentation
ZA200105919B (en) Antitachycardial pacing.
GB9911863D0 (en) Therapeutic agents
AU7574601A (en) Tissue implant
AU6905500A (en) Foam-on-film medical articles
IL148718D0 (en) Pyrazolopyrimidines as therapeutic agents
AU5585001A (en) Catheter assembly for treating ischemic tissue
AU8964001A (en) Intracardiac blood pump
AU9460401A (en) Improved radiation therapy treatment method
GB9905010D0 (en) Therapeutic agents
IL144593A (en) Cardiac valve procedure devices
GB2349091B (en) Defibrillator
AU6055000A (en) Treatment of skin damage using polyenylphosphatidylcholine
GB0009606D0 (en) Therapeutic combinations
AU2002359778A8 (en) Cardiac rhythm management system
HK1048586A1 (en) Tissue volume reduction.
AUPQ893200A0 (en) Medical residue treatment
GB9927687D0 (en) Therapeutic agents
IL158618D0 (en) Biological pacemaker
AUPQ514600A0 (en) Brain injury treatment
AU6209900A (en) Fabric treatment applicator
AU6282901A (en) Medical arrangement
IL161957D0 (en) Device and procedure to treat cardiac atrial arrhythmias
AU7517701A (en) Cardiac disease treatment and device